Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20080257345 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 12/075,470
Fecha de publicación23 Oct 2008
Fecha de presentación11 Mar 2008
Fecha de prioridad16 Abr 2003
También publicado comoCA2520708A1, CA2520708C, CA2736640A1, CA2736640C, CA2785936A1, EP1613380A1, EP2314337A1, US7360537, US20050005929, WO2004091704A1
Número de publicación075470, 12075470, US 2008/0257345 A1, US 2008/257345 A1, US 20080257345 A1, US 20080257345A1, US 2008257345 A1, US 2008257345A1, US-A1-20080257345, US-A1-2008257345, US2008/0257345A1, US2008/257345A1, US20080257345 A1, US20080257345A1, US2008257345 A1, US2008257345A1
InventoresSarah Bruce Snyder, James N. Schmidt
Cesionario originalTrudell Medical International
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Antistatic medication delivery apparatus
US 20080257345 A1
Resumen
An aerosol medication delivery apparatus include a holding chamber having an input end and an output end and defining an interior space. In one embodiment, the holding chamber is antistatic and is made of a plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq. In another embodiment, a component, such as a backpiece or mouthpiece, separate from the holding chamber, is antistatic and is made of a material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq. The component is connected to the holding chamber, which may or may not be antistatic. In one embodiment, the component is made of an elastomeric material. In one embodiment, at least a portion of the holding chamber and/or component is see-through. Various methods for introducing an aerosol into the holding chamber at the input end thereof and inhaling the aerosol through the output end are also provided.
Imágenes(7)
Previous page
Next page
Reclamaciones(19)
1-46. (canceled)
47. A medication delivery apparatus comprising:
an holding chamber comprising a plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq, wherein said holding chamber has an input end and an output end spaced apart along a longitudinal axis;
a patient interface communicating with said output end, said patient interface and said holding chamber defining a flow path for an inhalation flow;
a viewing port located adjacent said flow path; and
a visual flow indicator visible through said viewing port and moveable between at least an at-rest position and an inhalation position so as to provide a visual cue about said inhalation flow.
48. The medication delivery apparatus of claim 47 further comprising a one-way valve disposed adjacent said output end, said one-way valve moveable between an open position allowing said inhalation flow and a closed position.
49. The medication delivery apparatus of claim 47 wherein said viewing port is coupled to said patient interface.
50. The medication delivery apparatus of claim 49 wherein said viewing port and said patient interface are integrally formed.
51. The medication delivery apparatus of claim 47 wherein said patient interface comprises a plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq.
52. The medication delivery apparatus of claim 47 wherein said viewing port comprises a see-through plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq.
53. The medication delivery apparatus of claim 47 wherein said plastic material comprises a polypropylene material.
54. The medication delivery apparatus of claim 47 wherein said plastic material is selected from the group consisting of polypropylene, polycarbonate, polystyrene, nylon, acrylonitrile butadiene styrene, high density polyethylene, acetal, polybutylene terephthalate, and polyethylene terephthalate glycol.
55. The medication delivery apparatus of claim 47 wherein said surface resistivity of said plastic material is between about 10E10 and about 10E11 ohm/sq.
56. A method of delivering a medication comprising:
introducing a medication into a holding chamber through an input end of said holding chamber, wherein said holding chamber comprises a plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq;
moving said medication through said holding chamber from said input end to an output end spaced from said input end along a longitudinal axis;
moving said medication from said output end to a patient interface;
inhaling said medication through said patient interface;
moving a visual indicator from an at-rest position to an inhalation position simultaneously with said inhaling said medication through said patient interface; and
viewing said visual indicator through a viewing port.
57. The method of claim 56 wherein said moving said medication from said output end to said patient interface comprises moving said mediation through a one-way valve disposed adjacent said output end.
58. The method of claim 56 wherein said viewing port is coupled to said patient interface.
59. The method of claim 58 wherein said viewing port and said patient interface are integrally formed.
60. The method of claim 56 wherein said patient interface comprises a plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq.
61. The method of claim 56 wherein said viewing port comprises a see-through plastic material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq.
62. The method of claim 56 wherein said plastic material comprises a polypropylene material.
63. The method of claim 56 wherein said plastic material is selected from the group consisting of polypropylene, polycarbonate, polystyrene, nylon, acrylonitrile butadiene styrene, high density polyethylene, acetal, polybutylene terephthalate, and polyethylene terephthalate glycol.
64. The method of claim 56 wherein said surface resistivity of said plastic material is between about 10E10 and about 10E11 ohm/sq.
Descripción
  • [0001]
    This application is a continuation of U.S. application Ser. No. 10/821,260, filed Apr. 8, 2004, which claims the benefit of U.S. Provisional Application Ser. No. 60/463,288, filed Apr. 16, 2003, the entire disclosures of which are hereby incorporated herein by reference.
  • BACKGROUND
  • [0002]
    The present invention relates to a medication delivery apparatus, and in particular, to an antistatic medication delivery apparatus.
  • [0003]
    Medication delivery systems are used, in general, to administer medication to a user. For example, aerosol delivery systems are configured to deliver a medication in aerosol form to the lungs of the user. Other systems deliver the medication to the nasal passageways of the user. Some systems use a pressurized metered-dose inhaler (pMDI), which typically includes a container in which medication particles are stored under pressure, and an actuator used to dispense the medication from the container.
  • [0004]
    In other systems, a holding chamber or spacer is connected to one of the container or actuator, as shown for example in U.S. Pat. No. 6,293,279, which is hereby incorporated herein by reference. The holding chamber reduces the need for the user to coordinate activation of the pMDI canister with inhalation, helps reduce the delivery of nonrespirable medication particles from the canister, and helps reduce the impaction of medication particles in the user's oropharnyx and upper airway. In some configurations, shown for example in the U.S. Pat. No. 6,293,279 and U.S. Pat. No. 5,881,718, the apparatus can be provided with one or both of an inhalation and exhalation valve(s) at an output end of the chamber. The output end is typically configured with a mouthpiece, which is received in the mouth of the user, or with a mask, which is placed over the mouth and nose of the user.
  • [0005]
    Often, holding chamber devices are made of various plastics, such as polypropylene or polycarbonates. However, plastic materials typically have relative high surface resistivities, typically greater than 10E12 ohm/sq. As such, the interior of the chamber can become electrostatically charged, thereby causing some of the medication particles in the aerosol to deposit on the walls and/or other parts attached to or forming part of the holding chamber. As disclosed in U.S. Pat. No. 6,435,176, for example, one solution to this problem is to provide a spacer made of metal or other materials having resistivities below 10E9 ohm. However, metal spacers or holding chambers, made for example of stainless steel or aluminum, are relatively expensive to manufacture and are heavy and more difficult to handle. In addition, metal spacers or holding chambers do not allow the user or caregiver to visualize the delivery of medication from the chamber. Likewise, many plastics, if formed with antistatic additives, such as metal fibers, are not see-through and can obstruct a view of the interior of the chamber. In addition, plastic components having an antistatic surface coating can tend to degrade and lose their antistatic properties over time, e.g., within about a year.
  • [0006]
    Another solution is to periodically wash a plastic holding chamber with a detergent. However, such a solution can be cumbersome. Accordingly, the need remains for an improved holding chamber made of plastic, preferably clear, having inherent substantially permanent antistatic properties.
  • SUMMARY
  • [0007]
    By way of introduction, various preferred embodiments of an aerosol medication delivery apparatus include a holding chamber having an input end and an output end and defining an interior space. In one embodiment, the holding chamber is antistatic and is made of a plastic material having a surface resistivity of less than about 10E12 ohm/sq, and preferably between about 10E10 and about 10E12 ohm/sq. In one preferred embodiment, at least a portion of the holding chamber is see-through. In addition, the antistatic properties are substantially permanent.
  • [0008]
    In another embodiment, a component, separate from the holding chamber, is antistatic and is made of a material having a surface resistivity of between about 10E10 and about 10E12 ohm/sq. The component is connected, directly or indirectly, to the holding chamber, which may or may not be antistatic. In one preferred embodiment, the component is a backpiece connected to an input end of the holding chamber. In one embodiment, the backpiece is made of an elastomeric material. In another embodiment, the component includes a mouthpiece connected to the output end of the holding chamber.
  • [0009]
    In other aspects, various methods are provided that include introducing an aerosol into the holding chamber at the input end thereof and inhaling the aerosol through the output end.
  • [0010]
    The various embodiments provide significant advantages over other holding chamber devices. For example, both the holding chamber and component, such as the backpiece, can be made of various plastic and/or elastomeric materials, which are relatively light weight and inexpensive to manufacture. At the same time, one or more of the holding chamber and components can be made antistatic, such that the medication particles in the aerosol are less likely to be attracted to the interior surface of the holding chamber or components, thereby providing improved consistency in the amount of medication delivered to the patient without pretreating the delivery apparatus. In addition, the plastic material can be made see-through, such that the user or caretaker can monitor and visualize the interior of the holding chamber and/or component. Moreover, the antistatic properties are substantially permanent, such that they do not degrade over time.
  • [0011]
    The foregoing paragraphs have been provided by way of general introduction, and are not intended to limit the scope of the following claims. The presently preferred embodiments, together with further advantages, will be best understood by reference to the following detailed description taken in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0012]
    FIG. 1 is a perspective view of a first embodiment of an aerosol medication delivery system.
  • [0013]
    FIG. 2 is an exploded perspective view of the aerosol medication delivery system shown in FIG. 1.
  • [0014]
    FIG. 3 is a side cross-sectional view of an alternative embodiment of a holding chamber.
  • [0015]
    FIG. 4 is a side cross-sectional view of an alternative embodiment of a medication delivery system.
  • [0016]
    FIG. 5 is a side cross-sectional view of an alternative embodiment of a medication delivery system.
  • [0017]
    FIG. 6 is an exploded perspective view of an alternative embodiment of a medication delivery system.
  • [0018]
    FIG. 7 is an exploded perspective view of an alternative embodiment of a medication delivery system.
  • [0019]
    FIG. 8 is an exploded perspective view of an alternative embodiment of a medication delivery system.
  • [0020]
    FIG. 9 is an exploded perspective view of an alternative embodiment of a medication delivery system.
  • [0021]
    FIG. 10 is a partial side view of an output end of an alternative embodiment of a holding chamber.
  • [0022]
    FIG. 11 is a perspective view of one embodiment of a dry powder inhaler.
  • [0023]
    FIG. 12 is a top view of an alternative embodiment of a dry powder inhaler.
  • [0024]
    FIG. 13 is an end view of the dry powder inhaler shown in FIG. 12.
  • [0025]
    FIG. 14 is an exploded perspective view of an alternative embodiment of a dry powder inhaler.
  • [0026]
    FIG. 15 is a perspective view of the dry powder inhaler shown in FIG. 14.
  • [0027]
    FIG. 16 is a side view of a nasal inhaler.
  • DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • [0028]
    Referring to FIGS. 1, 2 and 6, one preferred embodiment of an aerosol medication delivery system 50 includes a pressurized metered dose inhaler (pMDI) holding portion 2, or dispenser (sometimes referred to as an actuator boot), coupled to a chamber housing 4, otherwise referred to as a holding chamber, at an input end 6 thereof. A medication container 8, for example a pMDI canister, is disposed in a cavity 12 formed in the dispenser, with a stem of the canister being inserted into a well 10 formed in the bottom of the dispenser. Preferably, the dispenser 2 is pivotally connected to the chamber housing 4 so that the dispenser 2 can be pivoted and translated for storage inside the chamber housing when the device is not in use. The term “medication” or “medicament” and variations thereof as used herein means any substance used in therapy, for example in the treatment of asthma.
  • [0029]
    In various alternative embodiments shown in FIGS. 3, 4 and 7-9, the apparatus includes a backpiece 22 secured to a holding chamber 20, 90 at an input end 52, 94 thereof. The backpiece 22, which is preferably formed as a separate component from the holding chamber, includes an opening 24 shaped to receive a mouthpiece portion 54 of a separate pMDI dispenser 156, which holds the container 8. Various configurations of chamber housings and dispensers are shown in U.S. Pat. Nos. 6,293,279, 5,012,803 and 5,012,804, the entire disclosures of which are hereby incorporated herein by reference. It should be understood that a holding chamber can also be used in conjunction with medication delivery containers other than a pMDI container, including for example and without limitation nasal sprayers, dry powder inhalers and nebulizer systems.
  • [0030]
    In yet another embodiment, shown in FIG. 5, the apparatus includes a holding chamber 70 that can be introduced into the inspiratory flow path of a ventilator circuit 302. The apparatus includes a backpiece member 72, configured with a pMDI receptacle 76, which is connected to the input end 79 of the holding chamber. The receptacle 76 is configured as a cylindrical housing shaped to receive the pMDI container and includes a well 10 formed at the bottom of the receptacle shaped to receive a pMDI valve stem 78. A discharge opening 80 is formed in the receptacle and communicates with the well 10, thereby allowing the aerosol, and medication, to be introduced into an interior 32 of the holding chamber through the backpiece 72 and input end 74 of the holding chamber.
  • [0031]
    In all of the embodiments, the chamber housing 4, 20, 70 defines an interior space 19, 56, 82 and further includes an output end 14, 58, 84, 94, through which the medication is dispensed to the user. The holding chamber 20 can have a substantially circular cross section as shown for example in FIG. 7, or the holding chamber 4 can have other shapes, for example a substantially oval cross-section as shown in FIG. 1 or an elliptical or rectangular cross-section (not shown). In addition, the holding chamber 20 can have a substantially constant cross-section, for example forming a cylinder as shown in FIG. 7, or the holding chamber 20 can be tapered, such that the cross-sectional area gradually increases from the input end 92 to the output end 94 as shown in FIGS. 8 and 9, or decreases along the same path (not shown).
  • [0032]
    As shown in the embodiments of FIGS. 1-3 and 6-8, the output end 14, 58, 84, 94 includes a downstream portion 23 that is configured with a mouthpiece 102, 104, 106, 108, 110. The mouthpiece 102, 106, 108, 110 can be formed as a separate component that is releasably secured to a main housing 21 with one or more fastening elements 25, 27, as shown for example in FIGS. 1, 2, and 4-8. For example, the fastening elements can be configured as tabs 25 and recesses 24 in one preferred embodiment, which provides a snap-fit between the main housing 21 and the downstream portion 23. As shown in FIG. 3, the mouthpiece 104 can alternatively be formed integrally with the housing.
  • [0033]
    The term “component” as used herein means any part, member, device, or feature that forms part of the medication delivery apparatus, and includes without limitation, the chamber housing, the backpiece, the mouthpiece, the output end, various adapters, baffle members, actuators, valve assemblies, tubes or conduits, masks, and the like, and portions thereof, which are incorporated into the system. The terms “connected” and “secured,” and variations thereof, as used herein, means that one or more members are associated or coupled to each other, either directly or indirectly (for example with intervening members).
  • [0034]
    In one alternative embodiment, shown in FIG. 10, an adapter 30 includes an input end 32 configured as an insert portion that is fitted in an opening formed in an output end 64 of a chamber housing 66. Conversely, the input end 32 can be fitted over or around an end portion of the chamber housing. In one embodiment, the adapter includes a narrow orifice, as disclosed for example in U.S. Provisional Patent Application Ser. No. 60/377,528, filed May 3, 2002 and entitled “Aerosol Medication Delivery Apparatus With Narrow Orifice,” the entire disclosure of which is hereby incorporated herein by reference. The adapter further includes an output end 34 that, in one preferred embodiment, is shaped to be received in the mouth of the user. For example, the output end 34 can have an outer circular cross-section, or it can be elliptical, oval, obround or any other shaped suitable for insertion into the mouth of the user. Alternatively, an additional mouthpiece (not shown) can be fitted in or around the output end.
  • [0035]
    In yet another alternative embodiment, shown in FIG. 9, a mask 160 is fitted in or around, i.e. a connector member 300, secured to the output end of the holding chamber. The mask 160 is shaped to be disposed over the face, preferably including the mouth and nose, of the user. In yet another alternative embodiment, a nasal applicator (not shown), provided for example with prongs, can be fitted into or around the output end. In yet another embodiment, a patient interface element, such as an endotracheal tube, can be fitted to one or more of the output end of the holding chamber or adapter.
  • [0036]
    In all of the embodiments, shown for example in FIGS. 1-9, the output end 14, 58, 84, 94 of the holding chamber 4, 20, 70, 90 can be configured with a baffle member 200. The baffle member 200 is preferably curved, and can have one or more concave or convex surfaces facing toward and away from the input end of the holding chamber. Of course, it should be understood that the baffle member 200 can be flat, or have other non-curved shapes. In addition, it should be understood that the apparatus can be configured without a baffle formed at the output end of the holding chamber.
  • [0037]
    As shown in FIGS. 6-9, the output end of the holding chamber can be configured with one or both of an inhalation and exhalation valve 220. In one embodiment, shown in FIG. 7, the valve 220 includes a central open area 224 having a peripheral edge portion 226 that seats on a valve seat formed on a center baffle portion 228 of the baffle member 200. The valve is displaced from the seat during inhalation. An outer peripheral portion 230 of the valve is seated on a second valve seat and is displaced therefrom during exhalation. Of course, it should be understood that other valve configurations, such as a duckbill valve, can also be used.
  • [0038]
    The valve member 220 is preferably made of a flexible material, including for example and without limitation a silicone, a thermoplastic elastomer, rubber, Ethylene-Propylene-Diene-Monomer (EPDM) or Berfluodelaastomers (FFKN).
  • [0039]
    Preferably, the adapter 30 and the chamber housing 4, 20, 70, 90 are made of a hard antistatic plastic, for example by injection molding. Typically, plastics have a surface resistivity of greater than 10E12 ohm/sq. Antistatic materials have a surface resistivity of between about 10E10 ohm/sq and about 10E12 ohm/sq. Static dissipative materials have a surface resistivity of between about 10E6 ohm/sq. and about 10E12 ohm/sq. Conductive materials have a surface resistivity of between about 10E1 ohm/sq and about 10E6 ohm/sq. Metals typically have a surface resistivity of between about 10E-1 to about 10E-5 ohm/sq. Surface resistivity as set forth herein is measured pursuant to ASTM test D257.
  • [0040]
    In various embodiments, the chamber housing 4, 20, 70, 90, adapter 30, mouthpiece 102, 106, 108, 110, and/or backpiece 22, 72 are made of one or more of a polypropylene, polycarbonate, polystyrene, nylon, ABS, high density polyethylene (HDPE), acetal, PBT, PETG, various thermoplastic elastomers, and/or combinations thereof. For example, the components can be made of various PermaStat® compounds available from the RTP Company, having a place of business at 580 East Front Street, Winona, Minn., 55987. Of course, it should be understood that materials other than PermaStat® compounds are suitable. In any event, the materials preferably have a surface resistivity of less than about 10E12 ohm/sq, more preferably between about 10E1 and about 10E12 ohm/sq, more preferably between about 10E6 and about 10E12 ohm/sq, more preferably between about 10E10 and about 10E12 ohm/sq, and most preferably between about 10E10 and about 10E11 ohm/sq.
  • [0041]
    In various exemplary embodiments, and without limitation, the chamber housing 4, 20, 70, 90, adapter 30, mouthpiece 102, 106, 108, 110, and backpiece 22, 72 can be made from one or more of a PermaStat® 100 series polypropylene material, a PermaStat® 200 series Nylon (PA6, PA6/6 or P12) material, a PermaStat® 300 series polycarbonate material, a PermaStat® 400 series polystyrene (PS) material, a PermaStat® 600 series Acrylonitrile Butadiene Styrene (ABS) material, a PermaStat® 700 series high density polyethylene (HDPE) material, a PermaStat® 800 series Acetal (POM) material, a PermaStat® 1000 series polybutylene Terephthalate (PBT) material, a PermaStat® 1100 series polyethylene Terephthalate Glycol modified (PETG) material, a PermaStat® 1200 series polyurethane thermoplastic elastomer material, a PermaStat® 1500 series polyester thermoplastic elastomer, a PermaStat® 1800 series acrylic (PMMA) material, a PermaStat® 2500 series polycarbonate/ABS alloy material, a PermaStat® 2700 series Styrenic thermoplastic elastomer (TES) material, a PermaStat® 2800 series Olefinic thermoplastic elastomer (TEO) materials, or a PermaStat® 4700 series polytrimethylene Terephthalate (PTT) material, all being permanently anti-static and having a surface resistivity between about 10E10 and about 10E11 ohms/sq with electrical shock discharge (ESD) protection. PermaStat® compounds are colorable and retain the transparency of the host resin. Such compounds are further free of carbon black, and are non-sloughing, meaning they do not release conductive contaminants. The compounds are further formulated to meet MIL-PRF-81705D static decay requirements. Since the compound is compounded into the molded material, the component is more robust and can function in all humidity levels. The term “plastic” as used herein includes thermoplastic elastomer materials.
  • [0042]
    Preferably, the chamber housing 4, 20, 70, mouthpiece 102, 106, 108, 110 and adapter 30 are made of an RTP 199 X 95281 S Nat/Clear, available from the RTP Company. Another suitable material is the RTP 199 X 95281 U Nat/Clear material, which is a high temperature material, also available from RTP Company.
  • [0043]
    Preferably, the backpiece 22, 72 is made of one or more of the elastomeric materials, or other elastomers available from RTP, including for example the RTP 1200 series Polyurethane elastomers, the 1500 series copolyester elastomers, the 2700 series styrenic elastomers and/or the 2800 series olefinic elastomers. It should be understood that the backpiece 22, 72 also can be made of non-elastomeric materials. In addition, it should be understood that the holding chamber 4, 20, 70, 90, and various components, including without limitation, the adapter, mouthpiece and backpiece can be made of materials that are not antistatic, having for example surface recitatives of greater than 10E12 ohm/sq. Therefore, for example, the delivery apparatus may be configured with only the holding chamber 4, 20, 70, 90 being antistatic, only one or more of the various components being antistatic, such as the backpiece, mouthpiece and/or adapter but not the holding chamber, or all of the components including the holding chamber being antistatic.
  • [0044]
    Preferably, the antistatic material is substantially clear, such that at least a portion of the various components, including without limitation the holding chamber, backpiece, mouthpiece and adapters, are see-through such that the user can monitor the interior of the delivery apparatus. In this way, the term “clear” simply means see-through, and includes materials that are completely transparent, as well as materials that are opaque or shaded, so long as an object is visible on the other side of the material. For example, by providing one or more see-through components, various visual flow indicators can be seen. Such visual indicators are shown for example in U.S. Provisional Application 60/382,227, filed May 21, 2002, the entire disclosure of which is hereby incorporated herein by reference. In addition, the antistatic properties associated with various afore-described materials are substantially permanent, and will not dissipate over time.
  • [0045]
    In other embodiments, the holding chamber 4, 20, 70, 90, and other components, including for example and without limitation the adapter 30, mouthpiece 102, 106, 108, 110 and backpiece 22, 72, are made of various thermoplastics using various levels of additives, including without limitation, stainless steel fibers, carbon fibers and carbon powder. It should be understood that an antistatic coating also can be applied to the chamber housing and components, such as the adapter, mouthpiece and backpiece to achieve the desired resistivities.
  • [0046]
    In operation, the user actuates the dispenser 2, 156 or other device, so as to discharge a medication, preferably in aerosol form, through the input end 6, 52, 74 and introduce the medication into the interior space 19, 56, 82 of the holding chamber 4, 20, 70, 90, or chamber housing. The medication is thereafter delivered to the user, for example by inhalation through the output end 14, 58, 84 of the holding chamber, by way of one or more of a mouthpiece, mask or endotracheal tube. The antistatic properties of the holding chamber and backpiece reduce the likelihood that the medication particles will be attracted thereto.
  • [0047]
    Referring to FIGS. 10-15, exemplary powder medication delivery systems, or dry powder inhalers 400 are shown. Each inhaler 400 includes a holding chamber 402 and a mouthpiece 408. The inhaler shown in FIGS. 14 and 15, further includes a visual flow indicator 412 mounted within a viewing port area 410. The flow indicator moves within the port area to provide a visual cue to the patient or caretaker that the inhalation flow is adequate to properly administer the medication to the patient. Various aspects of the inhaler are further disclosed and shown in U.S. Provisional Patent Application Ser. No. 60/382,227, filed May 21, 2002, the entire disclosure of which is hereby incorporated herein by reference.
  • [0048]
    Referring to the inhaler in FIGS. 11-13, the inhaler 400 includes a holding chamber 402 and a mouthpiece 408, which can be separate from (FIG. 11) or integral with (FIGS. 12-13) the holding chamber. The inhaler further includes a medicament holding cassette 414, which has a plurality of holding portions 416 that hold a plurality of dose of medication, each of which can be subsequently exposed to the interior of the holding chamber. One or more air entry passageways 418 are directed at the holding portions 416 and fluidize the medication within the holding chamber, wherein it can be subsequently inhaled through the mouthpiece. Various aspects of the inhaler are further disclosed and shown in U.S. Pat. No. 6,116,239, the entire disclosure of which is hereby incorporated herein by reference.
  • [0049]
    It should be understood that any or all of the various components of the inhalers 400, including the holding chambers 402, mouthpieces 408, air intake passageways 418, cassettes 414, and/or holding portions 416, can be made of one or more of the various antistatic materials described herein.
  • [0050]
    Various nasal inhalers 500, an example of which is shown in FIG. 16, may also include one or more of a holding chamber 502 having an input end 510 and an output end formed as an outlet 506, an actuator (not shown) and an adapter 504, one or more of which may be made of the various antistatic materials described herein. One or more inlet valves 508 may be provided in the holding chamber 502. Various exemplary nasal inhalers and applicators are disclosed for example in U.S. patent application Ser. No. 09/834,037, filed Apr. 11, 2001, and U.S. patent application Ser. No. 10/121,931, filed Apr. 12, 2002, the entire disclosures of which is hereby incorporated herein by reference.
  • [0051]
    Although the present invention has been described with reference to preferred embodiments, those skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. As such, it is intended that the foregoing detailed description be regarded as illustrative rather than limiting and that it is the appended claims, including all equivalents thereof, which are intended to define the scope of the invention.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US3363833 *15 Jun 196516 Ene 1968Laerdal Asmund SigurdElastic bag for artificial respiration apparatus
US3896101 *16 Nov 197122 Jul 1975Askew Anthony BAdditive for plastic materials
US4183361 *27 Feb 197815 Ene 1980Russo Ronald DRespiratory exercising device
US4253468 *14 Ago 19783 Mar 1981Steven LehmbeckNebulizer attachment
US4429835 *13 Nov 19817 Feb 1984Inge BruggerSpray-diffuser
US4507118 *1 Jul 198326 Mar 1985Sterimatic Holdings LimitedFitments for injection devices
US4509515 *7 Feb 19839 Abr 1985Fisons PlcInhalation device
US4809692 *4 Jun 19877 Mar 1989Trudell MedicalPediatric asthmatic medication inhaler
US4832015 *19 May 198823 May 1989Trudell MedicalPediatric asthmatic inhaler
US4834083 *12 May 198830 May 1989Minnesota Mining And Manufacturing CompanyAerosol device
US4984158 *14 Oct 19888 Ene 1991Hillsman DeanMetered dose inhaler biofeedback training and evaluation system
US5012803 *6 Mar 19897 May 1991Trudell MedicalModular medication inhaler
US5012804 *23 May 19907 May 1991Trudell MedicalMedication inhaler with adult mask
US5312281 *8 Dic 199217 May 1994Tdk CorporationUltrasonic wave nebulizer
US5383470 *20 Sep 199324 Ene 1995Steve NovakPortable spirometer
US5385140 *6 Oct 199331 Ene 1995Lindrew Pty LimitedAerosol inhalation device
US5431154 *16 Abr 199311 Jul 1995Seigel; DavidIncentive metered dose inhaler
US5497765 *24 Ene 199512 Mar 1996Rd-Chus Inc.Device for the simultaneous delivery of beta-2 agonists and oxygen to a patient
US5522380 *18 Ene 19954 Jun 1996Dwork; PaulMetered dose medication adaptor with improved incentive spirometer
US5613489 *7 Dic 199425 Mar 1997Westmed, Inc.Patient respiratory system drug applicator
US5645049 *5 Jul 19948 Jul 1997Trudell Medical LimitedExhalation valve for face mask with spacer chamber connection
US5704344 *6 Sep 19966 Ene 1998Cole; Jeanne M.Device for relieving anxiety in respiratory patients
US5724959 *16 Sep 199410 Mar 1998Aea Technology PlcPowder inhaler with specific orifice and baffle arrangement
US5724962 *14 Oct 199310 Mar 1998Orion-Yhtyma OyValve for use in connection with an inhaler apparatus
US5738087 *13 Dic 199614 Abr 1998King; Russell W.Aerosol medication delivery system
US5740793 *6 Jun 199521 Abr 1998Astra AktiebolagDry powder inhalation device with elongate carrier for power
US5740966 *6 Dic 199621 Abr 1998Paul Ritzau Pari-Werk GmbhNebulizer nozzle
US5755221 *24 Oct 199426 May 1998Bisgaard; HansAerosol inhaler with piston dump
US5758638 *15 May 19962 Jun 1998Kreamer; Jeffry W.Indicator for a medicament inhaler
US5765553 *27 Nov 199616 Jun 1998Diemolding CorporationAerosol medication delivery facemask adapter
US5775320 *22 Dic 19957 Jul 1998Inhale Therapeutic SystemsMethod and device for delivering aerosolized medicaments
US5855202 *8 Oct 19975 Ene 1999Andrade; Joseph R.Aerosol holding chamber for a metered-dose inhaler
US5865172 *8 Abr 19972 Feb 1999The Board Of Regents Of The University Of Texas SystemMethod and apparatus for induction of inhaled pharmacological agent by a pediatric patient
US5881718 *24 Mar 199516 Mar 1999Astra AktiebolagValve
US5890998 *30 Ene 19986 Abr 1999Hougen; Everett DouglasPortable personal breathing apparatus
US5896857 *20 Dic 199627 Abr 1999Resmed LimitedValve for use in a gas delivery system
US5899201 *26 May 19934 May 1999Minnesota Mining And Manufacturing CompanyAerosol actuator
US5925831 *14 Oct 199820 Jul 1999Cardiopulmonary Technologies, Inc.Respiratory air flow sensor
US6026807 *27 Feb 199822 Feb 2000Diemolding CorporationMetered dose inhaler cloud chamber
US6026808 *7 Jun 199922 Feb 2000Sheffield Pharmaceuticals, Inc.Methods and apparatus for delivering aerosolized medication
US6026809 *25 Ene 199622 Feb 2000Microdose Technologies, Inc.Inhalation device
US6039042 *23 Feb 199821 Mar 2000Thayer Medical CorporationPortable chamber for metered dose inhaler dispensers
US6044841 *29 Ago 19974 Abr 20001263152 Ontario Inc.Breath actuated nebulizer with valve assembly having a relief piston
US6044859 *3 Mar 19974 Abr 2000Filtertek IncValve apparatus and method
US6073628 *18 Sep 199813 Jun 2000The Board Of Regents Of The University Of Texas SystemApparatus for induction of inhaled pharmacological agent by a pediatric patient
US6085741 *30 Abr 199711 Jul 2000Pari Gmbh Spezialisten Fur Effektive InhalationDevice for atomisation of fluids
US6089105 *12 May 199918 Jul 2000Cardiopulmonary Technologies, Inc.Tubing connector
US6176237 *4 Ago 199823 Ene 2001Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy unit with a valve for limiting the inspiration flow
US6179164 *14 Abr 199930 Ene 2001Ing. Erich Pfeiffer GmbhDispenser for media, particularly powder
US6223745 *15 Oct 19971 May 2001Aga AktiebolagMethod and a device for producing a fine homogeneous aerosol
US6228346 *25 Abr 19978 May 2001Pari Gmbh Spezialisten Fur Effektive InhalationPropellant mixtures and aerosols for micronizing medicaments with compressed gas
US6240917 *20 Dic 19995 Jun 2001Joseph R. AndradeAerosol holding chamber for a metered-dose inhaler
US6253767 *10 Dic 19983 Jul 2001Robert F. MantzGas concentrator
US6257231 *3 Dic 199810 Jul 2001Ferraris Medical, Inc.Aerosol enhancement
US6345617 *26 Sep 199712 Feb 20021263152 Ontario Inc.Aerosol medication delivery apparatus and system
US6367471 *1 Nov 19999 Abr 2002Sheffield Pharmaceuticals, Inc.Internal vortex mechanism for inhaler device
US6412481 *23 Dic 19992 Jul 2002Robert BienvenuSealed backpressure attachment device for nebulizer
US6513519 *20 Dic 20004 Feb 2003Pari Gmbh Spezialsten Fur Effective InhalationInhalation atomizer with a one-piece valve element
US6513727 *15 Jun 19994 Feb 2003Pari Gmbh Spezialisten Fureffektive InhalationLiquid atomizer device
US6514177 *5 Nov 19964 Feb 2003Pari Gmbh Spezialisten Fur Effektive InhalationInhaling apparatus compressor with improved diaphragm assembly
US6557549 *11 Abr 20016 May 2003Trudell Medical InternationalAerosol delivery apparatus with positive expiratory pressure capacity
US6578571 *19 Abr 199917 Jun 2003Infamed Ltd.Drug delivery device and methods therefor
US6584971 *30 Jun 20001 Jul 2003Medic-Aid LimitedDrug delivery apparatus
US6595203 *28 Nov 200022 Jul 2003Forrest M. BirdApparatus for administering intermittent percussive ventilation and unitary breathing head assembly for use therein
US6679250 *6 Mar 200220 Ene 2004Joseph J. WalkerCombination inhalation therapeutic and exhalation measuring device
US6679251 *24 Ago 199920 Ene 2004Pari Gmbh Spezialisten Fur Effektive InhalationActuating device for meters and metering aerosol dispensing device with an actuating device for meters
US6679252 *28 Nov 200120 Ene 2004Thayer Medical CorporationCollapsible, disposable MDI spacer and method
US6708688 *11 Dic 200123 Mar 2004Darren RubinMetered dosage inhaler system with variable positive pressure settings
US6752145 *19 Abr 200022 Jun 2004Smithkline Beecham CorporationMedication dispenser
US6848443 *14 Mar 20031 Feb 2005Trudell Medical InternationalAerosol delivery apparatus with positive expiratory pressure capacity
US6904908 *7 May 200314 Jun 2005Trudell Medical InternationalVisual indicator for an aerosol medication delivery apparatus and system
US6983747 *23 Ene 200210 Ene 2006Pari GmbH Spezialisten für effektive InhalationAerosol generator
US7013896 *6 May 200221 Mar 2006Trudell Medical InternationalMask with inhalation valve
US7051731 *15 Nov 200230 May 2006Rogerson L KeithOxygen delivery system
US7059320 *16 Oct 200213 Jun 2006Pari Gmbh Spezialstein Fur Effektive InhalationInhalation therapy apparatus
US7077126 *19 May 200418 Jul 2006Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy mask and device for animals
US7201165 *17 May 200510 Abr 2007Trudell Medical InternationalMedication delivery apparatus and system having a visual indicator
US7360537 *8 Abr 200422 Abr 2008Trudell Medical InternationalAntistatic medication delivery apparatus
US20020005196 *6 Jun 200117 Ene 2002Pari Gmbh Spezialisten Fur Effektive InhalationPortable inhalator compressor device
US20020020762 *27 Jul 200121 Feb 2002Titus SelzerLiquid atomizer device
US20020056448 *30 Dic 199816 May 2002Kevin StapletonMouth piece for inhalation therapy units
US20030005929 *11 Sep 20029 Ene 20031263152 Ontario Inc.Nebulizer apparatus and method
US20030015193 *11 Sep 200223 Ene 20031263152 Ontario Inc.Nebulizer apparatus and method
US20030037785 *29 May 200227 Feb 2003Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy apparatus having a valve for limiting the inspiration flow
US20030037788 *29 May 200227 Feb 2003Pari Gmbh Spezialisten Fur Effektive InhalationInhalation mask
US20040000307 *27 Jun 20021 Ene 2004Khan Khaja H.Inhaler device
US20040089295 *23 Ene 200213 May 2004Thomas GallemAerosol generator
US20040094148 *14 Jul 200320 May 2004Amar LullaSpacer device for inhaler
US20050039741 *17 Sep 200424 Feb 2005Pari Innovative Manufacturers, Inc.Aerosol medication inhalation system
US20050056274 *26 Mar 200417 Mar 2005Pari Gmbh Spezialisten Fur EffektiveDevice for inhalation therapy
US20060011196 *17 Sep 200419 Ene 2006Pari Innovative Manufacturers, Inc.Aerosol Medication Inhalation System
US20060048772 *3 Ago 20059 Mar 2006Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy device
US20060054166 *7 Nov 200516 Mar 2006Pari Gmbh Spezialisten Fur Effektive InhalationInhalation nebulizer
US20060057073 *28 Oct 200316 Mar 2006Pari GmbhWet granulation process
US20060065267 *3 Nov 200530 Mar 2006Pari Innovative Manufacturers, Inc.Breath enhanced nebulizer with interchangeable top portions
US20060102172 *30 Oct 200318 May 2006Pari Gmbh Spezialisten Fur Effektive InhalationInhalation therapy device
US20060102178 *6 Jun 200318 May 2006Pari Gmbh Spezialisten Fur Effektive InhalationDevice for recording the parameters of an aerosol in particular in inhalation therapy devices
US20060162723 *3 Jul 200327 Jul 2006Pari Gmbh Spezialisten Fur EffektiveInhalation therapy device
USD355029 *16 Jul 199331 Ene 1995Boehringer Ingelheim International GmbhInhaler
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US79052283 Oct 200615 Mar 2011Trudell Medical InternationalNebulizer apparatus and method
US80613528 May 200722 Nov 2011Trudell Medical InternationalAerosol delivery apparatus and method
US8074642 *28 Feb 200713 Dic 2011Trudell Medical InternationalVisual indicator for an aerosol medication delivery apparatus and system
US825187622 Abr 200828 Ago 2012Hill-Rom Services, Inc.Breathing exercise apparatus
US85500677 Dic 20118 Oct 2013Trudell Medical InternationalVisual indicator for an aerosol medication delivery apparatus and system
US91802715 Mar 201210 Nov 2015Hill-Rom Services Pte. Ltd.Respiratory therapy device having standard and oscillatory PEP with nebulizer
US936461814 Ene 201414 Jun 2016Trudell Medical InternationalNebulizer apparatus and method
US970068918 Sep 201311 Jul 2017Trudell Medical InternationalMedication delivery apparatus and system and methods for the use and assembly thereof
US971351619 Ago 201425 Jul 2017Boehringer Ingelheim Vetmedica GmbhInhaler
US981484913 Abr 201614 Nov 2017Trudell Medical InternationalMedication delivery apparatus and system and methods for the use and assembly thereof
US20070107719 *3 Oct 200617 May 2007Trudell Medical InternationalNebulizer apparatus and method
WO2016145075A1 *9 Mar 201615 Sep 2016Alexza Pharmaceuticals, Inc.Use of antistatic materials in the airway for thermal aerosol condensation process
Clasificaciones
Clasificación de EE.UU.128/203.15
Clasificación internacionalA61M15/00
Clasificación cooperativaA61M15/009, A61M15/0086, A61M2205/0233
Clasificación europeaA61M15/00K